Humana CenterWell — Equity in net losses increased by 16.7% to -$15.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 25.0%, from -$12.00M to -$15.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Increasing losses indicate underperformance of the segment's strategic partnerships or minority investments.
Reflects the segment's share of losses from investments in entities where it holds significant influence but not full co...
Standard reporting for equity-method accounting in healthcare services segments with joint venture activity.
hum_segment_centerwell_equity_in_net_losses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.25M | $16.25M | $16.25M | -$4.00M | -$6.00M | -$14.00M | -$11.00M | -$12.00M | -$20.00M | -$22.00M | -$18.00M | -$15.00M |
| QoQ Change | — | +0.0% | +0.0% | -124.6% | -50.0% | -133.3% | +21.4% | -9.1% | -66.7% | -10.0% | +18.2% | +16.7% |
| YoY Change | — | — | — | — | -136.9% | -250.0% | -83.3% | — | — | -57.1% | -63.6% | -25.0% |